Platelet Reactivity Testing Round Table Session 2: Treatment Options for High-risk PCI Patients

Treatment Strategies - ESC 2011 - Accumetrics 2. Jurrien ten Berg - Platelet Reactivity TestingПодробнее

Drugs and devices synergy: optimal DAPT & switching strategies - Round Table WebinarПодробнее

Treatment Strategies - ESC 2011 - Accumetrics 1. Robert Storey - Platelet Reactivity TestingПодробнее

Platelet Reactivity Testing Round Table Discussion Session 1Подробнее

CTO PCI Vs OMT Roundtable Discussion: SESSION 4 - Working to Improve CTO PCI OutcomesПодробнее

The Clinical Value of Platelet Re-activity Testing - An IntroductionПодробнее

Workshop Presentation: The Latest on Platelet Reactivity in Blood Management & SurgeryПодробнее

VerifyNow Webinar - The Prognostic Value of Platelet Reactivity Testing after PCIПодробнее

CTO PCI Vs OMT Roundtable Discussion: SESSION 2 - Patient ApplicabilityПодробнее

TRIGGER-PCI Shows the Challenge of Personalized Antiplatelet TherapyПодробнее

Inside Interventions | Optimal Dual Antiplatelet DurationПодробнее

Optimizing the Benefit of Antiplatelet Therapy in High Risk Post-PCI PatientsПодробнее

Patient Outcomes and cost effectiveness of tailored dual anti platelet therapyПодробнее

VerifyNow Webinar on Antiplatelet Therapy Testing for Neurointerventional ProceduresПодробнее

TAVI Round Table - Session 5: TAVI ComplicationsПодробнее

Treatment Strategies - Accumetrics-sponsored Symposium on Platelet Reactivity Testing at ESC 2012Подробнее

Medicine Grand Rounds: Antiplatelet and Anticoagulation Therapy After PCI 1/28/20Подробнее

Balancing the Efficiency and Safety of Antiplatelet Agents in Acute Coronary Syndrome (ACS)Подробнее

Treatment Strategies - ESC 2012 - Accumetrics 1. Bernhard Witzenbichler - Platelet Reactivity TestПодробнее